ANTM logo

Elevance Health (ANTM) EBITDA

Annual EBITDA

$10.29 B
+$270.00 M+2.69%

31 December 2022

ANTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

$1.86 B
-$954.00 M-33.95%

31 December 2022

ANTM Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

$10.29 B
-$104.00 M-1.00%

31 December 2022

ANTM TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANTM EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+25.9%-27.2%+12.4%
5 y5 years+48.1%-6.0%+40.1%

ANTM EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-62.3%-1.0%

Elevance Health EBITDA History

DateAnnualQuarterlyTTM
Dec 2022
$10.29 B(+2.7%)
$1.86 B(-34.0%)
$10.29 B(-1.0%)
Sept 2022
-
$2.81 B(+2.4%)
$10.40 B(+2.6%)
June 2022
-
$2.74 B(-4.9%)
$10.14 B(-1.2%)
Mar 2022
-
$2.88 B(+47.2%)
$10.26 B(+2.3%)
Dec 2021
$10.03 B(+22.6%)
$1.96 B(-23.1%)
$10.03 B(+9.5%)
Sept 2021
-
$2.55 B(-11.1%)
$9.16 B(+22.0%)
June 2021
-
$2.87 B(+8.2%)
$7.50 B(-9.3%)
Mar 2021
-
$2.65 B(+142.7%)
$8.27 B(+1.2%)
Dec 2020
$8.18 B(+4.0%)
$1.09 B(+22.0%)
$8.18 B(-5.1%)
Sept 2020
-
$895.00 M(-75.4%)
$8.62 B(-11.1%)
June 2020
-
$3.64 B(+42.4%)
$9.70 B(+21.3%)
Mar 2020
-
$2.55 B(+66.4%)
$8.00 B(+1.7%)
Dec 2019
$7.86 B(+13.1%)
$1.53 B(-22.3%)
$7.86 B(+7.0%)
Sept 2019
-
$1.98 B(+2.1%)
$7.35 B(+3.6%)
June 2019
-
$1.93 B(-20.1%)
$7.09 B(-0.7%)
Mar 2019
-
$2.42 B(+137.4%)
$7.14 B(+2.7%)
Dec 2018
$6.95 B(+24.3%)
$1.02 B(-40.6%)
$6.95 B(+7.8%)
Sept 2018
-
$1.72 B(-13.3%)
$6.45 B(+3.6%)
June 2018
-
$1.98 B(-11.3%)
$6.22 B(+6.3%)
Mar 2018
-
$2.23 B(+332.9%)
$5.86 B(+4.7%)
Dec 2017
$5.59 B(-9.6%)
$516.00 M(-65.4%)
$5.59 B(-9.0%)
Sept 2017
-
$1.49 B(-7.6%)
$6.15 B(-0.7%)
June 2017
-
$1.61 B(-18.1%)
$6.19 B(-3.8%)
Mar 2017
-
$1.97 B(+84.5%)
$6.44 B(+4.0%)
Dec 2016
$6.19 B(-0.0%)
$1.07 B(-30.5%)
$6.19 B(+4.8%)
Sept 2016
-
$1.54 B(-17.3%)
$5.91 B(+4.8%)
June 2016
-
$1.86 B(+7.9%)
$5.63 B(-5.8%)
Mar 2016
-
$1.72 B(+119.6%)
$5.98 B(-3.4%)
Dec 2015
$6.19 B(+6.4%)
$785.30 M(-37.9%)
$6.19 B(-7.0%)
Sept 2015
-
$1.27 B(-42.6%)
$6.66 B(-2.7%)
June 2015
-
$2.20 B(+13.7%)
$6.84 B(+9.2%)
Mar 2015
-
$1.94 B(+55.2%)
$6.26 B(+7.6%)
Dec 2014
$5.82 B(+8.7%)
$1.25 B(-13.9%)
$5.82 B(+7.3%)
Sept 2014
-
$1.45 B(-10.9%)
$5.42 B(+3.6%)
June 2014
-
$1.63 B(+9.0%)
$5.24 B(+0.8%)
Mar 2014
-
$1.49 B(+74.9%)
$5.20 B(-2.9%)
Dec 2013
$5.35 B
$853.40 M(-32.4%)
$5.35 B(+0.7%)
Sept 2013
-
$1.26 B(-20.5%)
$5.32 B(-1.6%)
June 2013
-
$1.59 B(-3.6%)
$5.40 B(+4.6%)
DateAnnualQuarterlyTTM
Mar 2013
-
$1.65 B(+101.3%)
$5.16 B(+1.0%)
Dec 2012
$5.11 B(+1.7%)
$818.80 M(-39.2%)
$5.11 B(+1.0%)
Sept 2012
-
$1.35 B(-0.1%)
$5.06 B(+0.8%)
June 2012
-
$1.35 B(-15.6%)
$5.02 B(+1.7%)
Mar 2012
-
$1.60 B(+107.3%)
$4.94 B(-1.7%)
Dec 2011
$5.03 B(-6.5%)
$770.60 M(-41.0%)
$5.03 B(-4.8%)
Sept 2011
-
$1.31 B(+3.1%)
$5.28 B(-1.7%)
June 2011
-
$1.27 B(-24.8%)
$5.37 B(-2.0%)
Mar 2011
-
$1.68 B(+64.5%)
$5.48 B(+2.0%)
Dec 2010
$5.37 B(-36.1%)
$1.02 B(-26.8%)
$5.37 B(-42.0%)
Sept 2010
-
$1.40 B(+1.6%)
$9.27 B(+1.6%)
June 2010
-
$1.38 B(-12.5%)
$9.12 B(+2.0%)
Mar 2010
-
$1.57 B(-68.0%)
$8.94 B(+6.4%)
Dec 2009
$8.40 B(+101.8%)
$4.92 B(+292.1%)
$8.40 B(+82.6%)
Sept 2009
-
$1.25 B(+4.9%)
$4.60 B(+13.8%)
June 2009
-
$1.20 B(+15.4%)
$4.04 B(-3.2%)
Mar 2009
-
$1.04 B(-7.2%)
$4.18 B(+0.3%)
Dec 2008
$4.16 B(-28.5%)
$1.12 B(+60.8%)
$4.16 B(-8.0%)
Sept 2008
-
$694.60 M(-47.7%)
$4.52 B(-15.4%)
June 2008
-
$1.33 B(+29.7%)
$5.35 B(-2.2%)
Mar 2008
-
$1.02 B(-30.7%)
$5.47 B(-6.1%)
Dec 2007
$5.83 B(+6.9%)
$1.48 B(-2.8%)
$5.83 B(+7.6%)
Sept 2007
-
$1.52 B(+4.9%)
$5.42 B(+0.1%)
June 2007
-
$1.45 B(+4.9%)
$5.41 B(-2.2%)
Mar 2007
-
$1.38 B(+29.5%)
$5.53 B(+1.5%)
Dec 2006
$5.45 B(+14.7%)
$1.07 B(-29.4%)
$5.45 B(-9.6%)
Sept 2006
-
$1.51 B(-3.8%)
$6.03 B(+7.2%)
June 2006
-
$1.57 B(+20.7%)
$5.63 B(+11.5%)
Mar 2006
-
$1.30 B(-20.8%)
$5.05 B(+6.2%)
Dec 2005
$4.75 B(+154.7%)
$1.64 B(+48.2%)
$4.75 B(+30.1%)
Sept 2005
-
$1.11 B(+11.8%)
$3.65 B(+25.0%)
June 2005
-
$991.90 M(-1.3%)
$2.92 B(+22.4%)
Mar 2005
-
$1.01 B(+84.1%)
$2.39 B(+28.1%)
Dec 2004
$1.86 B(+629.8%)
$546.10 M(+44.1%)
$1.86 B(+41.4%)
Sept 2004
-
$379.10 M(-17.1%)
$1.32 B(+40.4%)
June 2004
-
$457.50 M(-5.1%)
$939.50 M(+94.9%)
Mar 2004
-
$482.00 M(-207.3%)
$482.00 M(+445.2%)
Dec 2002
$255.50 M
-$449.10 M(-247.3%)
$88.40 M(-83.6%)
Sept 2002
-
$304.80 M(+31.0%)
$537.50 M(+131.0%)
June 2002
-
$232.70 M
$232.70 M

FAQ

  • What is Elevance Health annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Elevance Health?
  • What is Elevance Health quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for Elevance Health?
  • What is Elevance Health TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for Elevance Health?

What is Elevance Health annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of ANTM is $10.29 B

What is the all time high annual EBITDA for Elevance Health?

Elevance Health all-time high annual earnings before interest, taxes, depreciation & amortization is $10.29 B

What is Elevance Health quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of ANTM is $1.86 B

What is the all time high quarterly EBITDA for Elevance Health?

Elevance Health all-time high quarterly earnings before interest, taxes, depreciation & amortization is $4.92 B

What is Elevance Health TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of ANTM is $10.29 B

What is the all time high TTM EBITDA for Elevance Health?

Elevance Health all-time high TTM earnings before interest, taxes, depreciation & amortization is $10.40 B